HER2-Positive Early Breast Cancer

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB06366Pertuzumab2Recruiting1
DB00072Trastuzumab2Recruiting1